Publication | Open Access

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

OncologyMetronomic TherapyRms 2005Maintenance ChemotherapyPharmacotherapyMetronomic ChemotherapyCancer TreatmentMedicineRadiation OncologyCancer ChemotherapyChemotherapyContinuous Low-dose Cyclophosphamide